NCT01687673 2020-12-07Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular CarcinomaUniversity of California, San FranciscoPhase 2 Completed29 enrolled 16 charts
NCT01010126 2019-01-25Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerNational Cancer Institute (NCI)Phase 2 Completed252 enrolled 20 charts